Khorshid Mohammad

Khorshid Mohammad

Auto-generated profile, based on publicly available information

Khorshid Mohammad

Section of Neonatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Pediatric Neurology
Verified
Journal Article
Closed access
PMPrashanth Murthy
Prashanth Murthy
HZHussein Zein
Hussein Zein
STSumesh Thomas
Sumesh Thomas
JSJames N. Scott
James N. Scott
AMAyman Abou Mehrem
Ayman Abou Mehrem
KMKhorshid Mohammad
Khorshid Mohammad

8 March 2021 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
KMKhorshid Mohammad
Khorshid Mohammad
JSJames N. Scott
James N. Scott
LLLara M. Leijser
Lara M. Leijser
HZHussein Zein
Hussein Zein
JAJehier Afifi
Jehier Afifi
PSPrakesh S. Shah
Prakesh S. Shah
Acquired brain injury remains common in very preterm infants and is associated with significant risks for short- and long-term morbidities. Cranial ultrasound has been widely adopted as the first-line neuroimaging modality to study the neonatal brain. It can reliably detect clinically significant abnormalities that include germinal matrix and intraventricular hemorrhage, periventricular hemorrhagic infarction, post-hemorrhagic ventricular dilatation, cerebellar hemorrhage, and white matter injury. The purpose of this article is to provide a consensus approach for detecting and classifying preterm brain injury to reduce variability in diagnosis and classification between neonatologists and radiologists. Our overarching goal with this work was to achieve homogeneity between different neonatal intensive care units across a large country (Canada) with regards to classification, timing of brain injury screening and frequency of follow up imaging. We propose an algorithmic approach that can help stratify different grades of germinal matrix-intraventricular hemorrhage, white matter injury, and ventricular dilatation in very preterm infants.

1 October 2021 in Seminars in Fetal and Neonatal Medicine
Verified
Journal Article
Closed access
AKA.G. Sandoval Karamian
A.G. Sandoval Karamian
SMSaadet Mercimek-Andrews
Saadet Mercimek-Andrews
KMK. Mohammad
K. Mohammad
EMEleanor Joan Molloy
Eleanor Joan Molloy
TCT. Chang
T. Chang
CWCourtney J. Wusthoff
Courtney J. Wusthoff

1 November 2016 in Pediatric Neurology
Verified
Journal Article
Closed access
RBRani Ameena Bashir
Rani Ameena Bashir
LELiza Espinoza
Liza Espinoza
SVSakeer Vayalthrikkovil
Sakeer Vayalthrikkovil
JBJeffrey Buchhalter
Jeffrey Buchhalter
LILeigh Irvine
Leigh Irvine
KMKhorshid Mohammad
Khorshid Mohammad

22 October 2019 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
IKIjab Khanafer-Larocque
Ijab Khanafer-Larocque
ASAmuchou Soraisham
Amuchou Soraisham
ASAmelie Stritzke
Amelie Stritzke
EAEssa Al Awad
Essa Al Awad
STSumesh Thomas
Sumesh Thomas
KMKhorshid Mohammad
Khorshid Mohammad
Objectives: To assess maternal and neonatal risk factors for intraventricular hemorrhage (IVH). To examine the association of patent ductus arteriosus (PDA) and its treatment, with IVH and its severity. Study design: In this retrospective cohort study, we included preterm neonates born at <29 weeks, admitted to a tertiary level III Neonatal Intensive Care Unit in Calgary, Canada, between 2013 and 2016, who had a head ultrasound in the first 7 days of life. A subset analysis included neonates who also had cardiac ultrasound in the first 3 days of life. Results: Of the 495 neonates, 121 (24.4%) had IVH of any grade and 48 (9.7%) had severe IVH. Identified risk factors were small birth gestation and weight, lack of antenatal corticosteroids, maternal chorioamnionitis, Apgar score <5 at 5 min, umbilical cord pH < 7, respiratory distress syndrome, early onset sepsis, hypercapnia, pCO2 fluctuations, prolonged intubation, inhaled nitric oxide, inotropes or normal saline boluses, metabolic derangements, opioids infusions, and bicarbonate/THAM therapy. In a primary analysis of the total cohort, when the decision to treat a PDA was used as a surrogate marker of its clinical significance, a PDA requiring treatment was associated with a higher risk of IVH. There was no significant difference in the incidence of IVH between neonates with early treatment of a clinically significant PDA compared to late, however early indomethacin treatment was associated with reduced severity of IVH. In the subset analysis, the presence of a hemodynamically significant PDA (hs-PDA) was not associated with a higher probability of IVH. Of those with severe IVH, 18 (55%) had a hs-PDA; this is clinically but not statistically significant. Conclusions: Identified risk factors should be the target of IVH reduction bundles. Early indomethacin treatment for a clinically significant PDA may reduce IVH severity.

22 January 2019 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
AAAhmad Nizar Abdul Aziz
Ahmad Nizar Abdul Aziz
STSumesh Thomas
Sumesh Thomas
PMPrashanth Murthy
Prashanth Murthy
YRYacov Rabi
Yacov Rabi
ASAmuchou Soraisham
Amuchou Soraisham
KMKhorshid Mohammad
Khorshid Mohammad
Introduction: Extremely premature infants are susceptible to fluctuations in cerebral blood flow due to immaturity of cerebral autoregulation. Inotropes may cause rapid changes to systemic blood pressure and consequently cerebral blood flow, especially within the first 72 hours of life. This period is recognized to carry the greatest risk for cerebral hemorrhage. This study evaluates the incidence of death and/or severe brain injury in extremely preterm infants treated with inotropes in the first 72 hours of life. Methods: Prospective cohort study of infants born ≤29+0 weeks gestational age (GA) between January 2013 and December 2016. Severe brain injury was defined based on head ultrasound as presence of: grade III or IV intraventricular hemorrhage (IVH), moderate to severe post hemorrhagic ventricular dilatation (PHVD), or cystic periventricular leukomalacia (cPVL). The association between inotrope use and death and/or brain injury was explored via logistic regression controlling for predefined confounding risk factors. Results: Of 497 eligible infants, 97 (19.5%) received inotropes during the first 72 hours. GA at birth, birth weight (BW), and 5-minute Apgar scores were lower among infants who received early inotropes compared to those not treated with inotropes. A stepwise logistic regression of the predefined confounding factors showed GA, exposure for antenatal steroids, and admission hypothermia to be significant confounding factors. Adjusting for those factors, early use of inotrope associated with increased risk of death and/or severe brain injury (AOR 4.5; 95%CI: 2.4–8.5), severe brain injury (AOR 4.2; 95% CI: 1.9–8.9), and IVH of any grade (AOR 2.9; 95%CI: 1.7–4.9). Conclusion: Early inotrope use associated with higher risk of death and/or severe brain injury. Strict indications and strategies for minimizing inotrope use while preventing hypotension should be implemented in the early postnatal care of infants at risk for severe brain injury.